The Superintendent Pharmacist in a Kenyan Pharma Company

Every company that runs a pharmacy, wholesale or distribution business in Kenya depends on one person: its superintendent pharmacist. The role is the legal condition that allows a company, rather than an individual pharmacist, to carry on the business of a pharmacist at all. Investors often treat it as a hiring decision. In law it is closer to a licence condition, and getting it wrong can invalidate the company’s right to trade and expose its directors to criminal liability. This guide explains what the Pharmacy and Poisons Act (Cap. 244) requires of a superintendent pharmacist, what it does not require, and how to structure the role properly.

Why a Company Needs a Superintendent

The Pharmacy and Poisons Act was written around the individual registered pharmacist. Section 21 creates the route for companies: a body corporate carrying on the business of a pharmacist does not itself need to be registered, provided four conditions are met:

• a copy of its certificate of incorporation is lodged with the Pharmacy and Poisons Board (PPB);
• the business is under the management of a superintendent who is a registered pharmacist and a member of the company’s board of directors, and who is not acting in a similar capacity for any other body corporate;
• in each set of premises, the retail sale of drugs is carried on by the superintendent or, under the superintendent’s direction, by a manager or assistant who is a registered pharmacist; and
• in each set of premises, the name and certificate of registration of the person in control of the business is conspicuously displayed.

If those conditions are not met, the company falls outside section 21 and is carrying on a business that the Act reserves for registered persons.

Directorship, Not Shareholding

A common misconception, especially among foreign investors, is that the superintendent must own the company or hold a majority of its shares. Section 21 does not say that. It requires the superintendent to be a registered pharmacist and a director. Nothing in the section requires a shareholding of any size.

That distinction matters for structuring. A foreign parent can own the Kenyan company outright and still comply with section 21 by appointing a qualified pharmacist to the board as superintendent. What the parent cannot do is treat the appointment as nominal. Investors should still confirm the PPB’s current registration requirements before incorporation, because the Board’s forms and practice can ask for more than the bare statutory conditions.

The exclusivity condition is just as important. A superintendent cannot act in that capacity for another company at the same time. A pharmacist who is already superintendent of a retail chain cannot simply be added to a new wholesaler’s board in the same role.

The Wholesale Overlay: A Resident Pharmacist in Control

For wholesalers, section 27(4) adds a further requirement. No wholesale dealer’s licence may be issued or renewed unless the applicant is, or has, a registered pharmacist in control of the distribution of the poisons, and that pharmacist is resident in Kenya. In most structures the superintendent fills this role too, which makes residence a practical requirement for the person appointed. A pharmacist based abroad will not satisfy it. Our guide to obtaining a pharmaceutical wholesale licence in Kenya covers the licence in full.

Personal Liability: Why the Role Cannot Be Nominal

The superintendent is a director, so the Act’s vicarious liability provision applies directly. Section 49(1) provides that an act that would be an offence if done by an individual is, if done by a company, an offence by every director, secretary and manager, unless that person proves the offence was committed without their consent or connivance and that they exercised all the diligence they ought to have exercised given their functions.

For a superintendent, whose function is to manage the pharmaceutical business, that defence is hard to make out if they were not actually managing it. The same section exposes the other directors, including foreign directors who never visit Kenya.

Name-lending arrangements, where a pharmacist is paid to allow their registration to be used while others run the business, are the clearest example of this risk. They leave the pharmacist exposed to criminal liability and professional discipline, the directors exposed under section 49, and the company exposed to losing its licences. Where the business handles narcotic or psychotropic medicines, the stakes rise sharply: dealing in those products outside a valid licence is trafficking under the Narcotic Drugs and Psychotropic Substances (Control) Act. See our guide to importing narcotic and psychotropic medicines into Kenya.

Changes in Ownership and Replacing a Superintendent

Two transitions need planning. The first is a change in ownership: under section 23(3), the registration of premises becomes void thirty days after any change in the ownership of the business carried on there. A buyer of a pharmaceutical business should engage the PPB before completion and build the regulatory steps into the transaction timetable. Our guide to M&A due diligence in Kenya’s healthcare sector covers the wider deal process.

The second is the departure of the superintendent. Because the company’s ability to trade depends on having one, the appointment letter or service agreement should require reasonable notice, an orderly handover and cooperation with the Board, and the company should keep a succession plan. A gap in the role is a gap in compliance.

Structuring the Role Properly

• Board appointment. Appoint the superintendent as a director by resolution, file the change with the Business Registration Service, and keep the PPB informed.
• Clear authority. Give the superintendent written authority over procurement, storage, dispensing and recalls, with a direct reporting line to the board.
• Real presence. Make sure the superintendent works in the business, not alongside another superintendent post.
• Protection. Consider directors’ and officers’ insurance and an indemnity, within the limits the Companies Act, 2015 allows.

Frequently asked questions

This article is general information on Kenyan law as at its publication date, not legal advice. Reading it does not create an advocate and client relationship.